← Back to graph
Prescription

zavegepant nasal Zavzpret

Selected indexed studies

  • Zavegepant: First Approval. (Drugs, 2023) [PMID:37227596]
  • Zavegepant Intranasal Spray for Migraines. (Ann Pharmacother, 2024) [PMID:37897226]
  • New Nasal Spray for Migraine Headaches. (Am J Nurs, 2023) [PMID:37345774]

_Worker-drafted node — pending editorial review._

Connections

zavegepant nasal Zavzpret is a side effect of

Sources

Local graph